Cargando…

Predictors for use of psychosocial services in patients with metastatic colorectal cancer receiving first line systemic treatment

BACKGROUND: Patients with advanced disease experience high levels of psychological distress, yet there is low uptake of psychosocial services offered to patients who screened positive for distress. In this study we aimed to identify predictors for use of psychosocial services in patients with metast...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schuurhuizen, Claudia S. E. W., Braamse, Annemarie M. J., Konings, Inge R. H. M., Verheul, Henk M. W., Dekker, Joost
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6359772/ https://www.ncbi.nlm.nih.gov/pubmed/30709384 http://dx.doi.org/10.1186/s12885-019-5318-9

Ejemplares similares

The predictive value of cumulative toxicity for quality of life in patients with metastatic colorectal cancer during first-line palliative chemotherapy
por: Schuurhuizen, Claudia SEW, et al.
Publicado: (2018)

Screening and treatment of psychological distress in patients with metastatic colorectal cancer: study protocol of the TES trial
por: Schuurhuizen, Claudia SEW, et al.
Publicado: (2015)

Economic evaluation of a combined screening and stepped-care treatment program targeting psychological distress in patients with metastatic colorectal cancer: A cluster randomized controlled trial
por: El Alili, Mohamed, et al.
Publicado: (2020)

Clinical management of emotions in patients with cancer: introducing the approach “emotional support and case finding”
por: Dekker, Joost, et al.
Publicado: (2020)

Clinical assessment of emotions in patients with cancer: Diagnostic accuracy compared with two reference standards
por: van Linde, Myra E., et al.
Publicado: (2020)

Combinatorial Immunotherapies for Metastatic Colorectal Cancer
por: Janssen, Eline, et al.
Publicado: (2020)

Muscle contractile properties of cancer patients receiving chemotherapy: Assessment of feasibility and exercise effects
por: Buffart, Laurien M., et al.
Publicado: (2020)

A specific microRNA profile as predictive biomarker for systemic treatment in patients with metastatic colorectal cancer
por: Poel, Dennis, et al.
Publicado: (2020)

Clinical judgment of the need for professional mental health care in patients with cancer: a qualitative study among oncologists and nurses
por: Karchoud, Jeanet F., et al.
Publicado: (2021)

Prophylactic treatment for delayed chemotherapy-induced nausea and vomiting after non-AC based moderately emetogenic chemotherapy: a systematic review of randomized controlled trials
por: van der Vorst, Maurice J. D. L, et al.
Publicado: (2015)

Safety and Feasibility of Additional Tumor Debulking to First‐Line Palliative Combination Chemotherapy for Patients with Multiorgan Metastatic Colorectal Cancer
por: Gootjes, Elske C., et al.
Publicado: (2020)

In Patients Undergoing CRS/HIPEC for Colorectal Adenocarcinoma with Peritoneal Metastases, Presence of Ascites on Computed Tomography Imaging is not a Prognostic Marker for Survival
por: Said, Ibrahim, et al.
Publicado: (2022)

Genomic landscape of metastatic colorectal cancer
por: Haan, Josien C., et al.
Publicado: (2014)

Copy number load predicts outcome of metastatic colorectal cancer patients receiving bevacizumab combination therapy
por: Smeets, Dominiek, et al.
Publicado: (2018)

Combination of NK Cells and Cetuximab to Enhance Anti-Tumor Responses in RAS Mutant Metastatic Colorectal Cancer
por: Veluchamy, John Pradeep, et al.
Publicado: (2016)

Circulating VEGF and eNOS variations as predictors of outcome in metastatic colorectal cancer patients receiving bevacizumab
por: Marisi, Giorgia, et al.
Publicado: (2017)

Symptom burden & quality of life among patients receiving second-line treatment of metastatic colorectal cancer
por: Walker, Mark S, et al.
Publicado: (2012)

Early (18)F-FDG PET/CT Evaluation Shows Heterogeneous Metabolic Responses to Anti-EGFR Therapy in Patients with Metastatic Colorectal Cancer
por: van Helden, Erik J., et al.
Publicado: (2016)

In Vivo Efficacy of Umbilical Cord Blood Stem Cell-Derived NK Cells in the Treatment of Metastatic Colorectal Cancer
por: Veluchamy, John P., et al.
Publicado: (2017)

Genome Wide Association Study for Predictors of Progression Free Survival in Patients on Capecitabine, Oxaliplatin, Bevacizumab and Cetuximab in First-Line Therapy of Metastatic Colorectal Cancer
por: Pander, Jan, et al.
Publicado: (2015)

Study protocol of the CORRECT multicenter trial: the efficacy of blended cognitive behavioral therapy for reducing psychological distress in colorectal cancer survivors
por: Leermakers, L., et al.
Publicado: (2018)

Glasgow PrognosticScore as a Predictor of BevacizumabEfficacy in the First-line Treatment with Metastatic Colorectal Cancer
por: Huang, Yuanyuan, et al.
Publicado: (2019)

Pre-treatment lactate dehydrogenase levels as predictor of efficacy of first-line bevacizumab-based therapy in metastatic colorectal cancer patients
por: Scartozzi, M, et al.
Publicado: (2012)

Inflammation-based markers can predict the prognosis of geriatric patients with metastatic colorectal cancer receiving first-line chemotherapy
por: Guo, Guifang, et al.
Publicado: (2019)

Recruitment problems in psychosocial oncology research
por: van Lankveld, Jacques J.D.M., et al.
Publicado: (2018)

Decoy receptor 1 (DCR1) promoter hypermethylation and response to irinotecan in metastatic colorectal cancer
por: Bosch, Linda J.W., et al.
Publicado: (2017)

Psychosocial Predictors of Bruxism
por: Przystańska, Agnieszka, et al.
Publicado: (2019)

Trends in Use and Perceptions About Triplet Chemotherapy Plus Bevacizumab for Metastatic Colorectal Cancer
por: van Nassau, Sietske C., et al.
Publicado: (2021)

Psychosocial consequences of receiving false-positive colorectal cancer screening results: a qualitative study
por: Toft, Eva Lykke, et al.
Publicado: (2019)

Imaging in Colorectal Cancer: Progress and Challenges for the Clinicians
por: Van Cutsem, Eric, et al.
Publicado: (2016)

Dendritic cell phenotype and function in a 3D co-culture model of patient-derived metastatic colorectal cancer organoids
por: Subtil, Beatriz, et al.
Publicado: (2023)

Distress and quality of life after autologous stem cell transplantation: a randomized clinical trial to evaluate the outcome of a web-based stepped care intervention
por: Braamse, Annemarie MJ, et al.
Publicado: (2010)

Antiretroviral therapy uptake and predictors of virological failure in patients with HIV receiving first-line and second-line regimens in Johannesburg, South Africa: a retrospective cohort data analysis
por: Gumede, Siphamandla Bonga, et al.
Publicado: (2022)

Pulsatile high-dose treatment with antiangiogenic tyrosine kinase inhibitors improves clinical antitumor activity
por: Rovithi, Maria, et al.
Publicado: (2017)

Effects of Cancer Presence and Therapy on the Platelet Proteome
por: Walraven, Maudy, et al.
Publicado: (2021)

Circulating Tumour DNA as Biomarker for Colorectal Liver Metastases: A Systematic Review and Meta-Analysis
por: Wullaert, Lissa, et al.
Publicado: (2023)

Perceptions of psychosocial disability amongst psychiatric service users and caregivers in South Africa
por: Brooke-Sumner, Carrie, et al.
Publicado: (2014)

Personalizing cognitive behavioral therapy for cancer-related fatigue using ecological momentary assessments followed by automated individual time series analyses: A case report series
por: Harnas, Susan J., et al.
Publicado: (2021)

Genetic variants in the Folic acid Metabolic Pathway Genes predict outcomes of metastatic Colorectal Cancer patients receiving first-line Chemotherapy
por: Jiang, Lu, et al.
Publicado: (2020)

Prospective validation of VEGF and eNOS polymorphisms as predictors of first-line bevacizumab efficacy in patients with metastatic colorectal cancer
por: Marisi, Giorgia, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_s856cnt3pk3bk7824uiemmh111